Pharmacological profile of people with chronic kidney failure in hemodialysis: a study in a city in the Western Amazon, Brazil

Objective: to analyze the pharmacological profile of patients with Chronic Renal Insufficiency (CRF) undergoing hemodialysis in a dialysis unit in a municipality in Rondônia, Western Amazon, Brazil. Method: It is a descriptive, applied, transversal research with a quantitative approach. The research was carried out at the Dialysis Centerof a city in the State of Rondônia, Western Amazonia Brazil. The sample included 92.3% of patients assisted at the Dialysis Center. Data were collected from two sources: data from medical records composed of variables of socio-economic characteristics and data from patients composed of variables of clinical and pharmacological characteristics. Results: Of the 120 patients who were part of the sample, 63% are men and 37% women; 75% of patients are between 18 and 58 years old; 82% are married; 58% receive sick pay; 55% have a monthly income of 1 to 2 minimum wages; 70% live in other locations outside the headquarters of the Dialysis Center and low education predominates. Systolic arterial hypertension (SAH) is the major cause of CRF (57%); The relative frequency of SAH as the underlying disease (62%), SAH comorbidity (78%), hematocrit change (98%), anemic corrective MP (98%), access condition = fisture (95%), report of another pathology (73%), alteration of phosphorus (48%) and phosphorus correcting PM (48%) were the main clinical characteristics found. Dialysis time from 6 months to 2 years (46%) and more than 2 years to 5 years (38%) prevails. As for pharmacological characteristics, 100% use drugs; 60% understand the guidelines; 50% receive pharmaceutical guidance; 80% know how to describe the drugs; 95% seek medical assistance; 80% follow the prescriptions; 60% use 3 to 4 medications daily. Conclusions: The reality of patients with CRF in this study does not differ much from other Brazilian realities. It is essential the role of the pharmacist who with their attributes can influence the understanding of the importance of treating underlying diseases, early diagnosis and the practice of self-care. The results presented show several aspects of the population of patients with CRF in the Amazon scenario, which will serve to support decisions to improve care for these patients, including the creation and long-term maintenance of a comprehensive registration system with data and information from socioeconomic, clinical and pharmacological characteristics, in addition to the monitoring and monitoring of patients in an environment outside the treatment center, the analysis and dissemination of epidemiological data on patients with CRF undergoing renal treatment at the Dialysis Center.